Member Exclusive

Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial

Available to view on demand. The UC Davis research team present an update on preclinical development of the cell-gene therapy product and the planned Phase I trial.

Go to the profile of RegMedNet
Sep 24, 2015
0
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.